US Stock MarketDetailed Quotes
XBIO Xenetic Biosciences
- 3.8300
- +0.0864+2.31%
Trading Jul 5 09:30 ET
5.90MMarket Cap-1307P/E (TTM)
3.8300High3.8200Low1.68KVolume3.8200Open3.7436Pre Close6.40KTurnover0.14%Turnover RatioLossP/E (Static)1.54MShares5.970052wk High0.68P/B4.50MFloat Cap2.869652wk Low--Dividend TTM1.17MShs Float59399.9505Historical High--Div YieldTTM0.27%Amplitude2.4010Historical Low3.8210Avg Price1Lot Size
About Xenetic Biosciences Company
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Company Profile
SymbolXBIO
Company NameXenetic Biosciences
Listing DateNov 7, 2016
Founded2011
CEOMr. James F. Parslow
MarketNASDAQ
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address945 Concord Street
CityFramingham
ProvinceMassachusetts
CountryUnited States of America
Zip Code01701
Phone1-781-778-7720
Websitehttp://www.xeneticbio.com
Company Executives
- Name
- Position
- Salary
- James F. Parslow
- Interim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 473.99K
- Adam E. Logal
- Chairman of the Board
- 59.56K
- Dr. Dmitry Genkin, PhD
- Director
- --
- Moshe Mizrahy
- Independent Director
- --
- Firdaus Jal Dastoor
- Independent Director
- 59.56K
- Dr. Roger D. Kornberg, PhD
- Independent Director
- 59.56K
- Dr. James Callaway,PhD
- Independent Director
- 59.56K
- Dr. Grigory G. Borisenko, PhD
- Independent Director
- 59.56K
- Dr. Alexey Vinogradov
- Independent Director
- 59.56K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg